Advertisement
BMI vs FCUV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMI is a Hold and FCUV is a StrongBuy.
BMI's Stochastic Oscillator driving into overbought zone
The Stochastic Oscillator for BMI moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BMI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 58 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for BMI just turned positive on October 09, 2026. Looking at past instances where BMI's MACD turned positive, the stock continued to rise in 32 of 47 cases over the following month. The odds of a continued upward trend are 68%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +15.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 183 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 53 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.597) is normal, around the industry mean (1.599). P/E Ratio (30.665) is within average values for comparable stocks, (7.243). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.013) settles around the average of (0.011) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
FCUV in downward trend: 10-day moving average broke below 50-day moving average on September 18, 2026
The 10-day moving average for FCUV crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FCUV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for FCUV entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for FCUV's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for FCUV just turned positive on October 08, 2026. Looking at past instances where FCUV's MACD turned positive, the stock continued to rise in 40 of 44 cases over the following month. The odds of a continued upward trend are 90%.
Following a +1.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where FCUV advanced for three days, in 218 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
FCUV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.280) is normal, around the industry mean (1.599). P/E Ratio (-0.161) is within average values for comparable stocks, (7.243). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.067) is also within normal values, averaging (32.028).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. FCUV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FCUV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
BMI | FCUV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 29 Undervalued | |
PROFIT vs RISK RATING 1..100 | 76 | 100 | |
SMR RATING 1..100 | 49 | 99 | |
PRICE GROWTH RATING 1..100 | 53 | 65 | |
P/E GROWTH RATING 1..100 | 64 | 76 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FCUV's Valuation (29) in the null industry is somewhat better than the same rating for BMI (77) in the Electronic Equipment Or Instruments industry. This means that FCUV’s stock grew somewhat faster than BMI’s over the last 12 months.
BMI's Profit vs Risk Rating (76) in the Electronic Equipment Or Instruments industry is in the same range as FCUV (100) in the null industry. This means that BMI’s stock grew similarly to FCUV’s over the last 12 months.
BMI's SMR Rating (49) in the Electronic Equipment Or Instruments industry is somewhat better than the same rating for FCUV (99) in the null industry. This means that BMI’s stock grew somewhat faster than FCUV’s over the last 12 months.
BMI's Price Growth Rating (53) in the Electronic Equipment Or Instruments industry is in the same range as FCUV (65) in the null industry. This means that BMI’s stock grew similarly to FCUV’s over the last 12 months.
BMI's P/E Growth Rating (64) in the Electronic Equipment Or Instruments industry is in the same range as FCUV (76) in the null industry. This means that BMI’s stock grew similarly to FCUV’s over the last 12 months.
| BMI | FCUV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 55% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 61% | N/A |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 60% | 4 days ago 84% |
| Declines ODDS (%) | 4 days ago 58% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 68% | 1 day ago 87% |
| Aroon ODDS (%) | 1 day ago 57% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BMI’s FA Score shows that 0 FA rating(s) are green while FCUV’s FA Score has 1 green FA rating(s).
- BMI’s FA Score: 0 green, 5 red.
- FCUV’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BMI’s TA Score shows that 4 TA indicator(s) are bullish while FCUV’s TA Score has 4 bullish TA indicator(s).
- BMI’s TA Score: 4 bullish, 3 bearish.
- FCUV’s TA Score: 4 bullish, 3 bearish.
Price Growth
BMI (@Electronic Equipment/Instruments) experienced а +2.65% price change this week, while FCUV (@Electronic Equipment/Instruments) price change was -6.24% for the same time period.
The average weekly price growth across all stocks in the @Electronic Equipment/Instruments industry was -3.39%. For the same industry, the average monthly price growth was -13.90%, and the average quarterly price growth was -16.41%.
Reported Earning Dates
BMI is expected to report earnings on Oct 22, 2026.
FCUV is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Electronic Equipment/Instruments (-3.39% weekly)This industry manufactures electronic products used in various critical and sophisticated technologies, including laser-based systems, circuit and continuity testers, electro-optical measuring instruments and high-speed precision weighing and inspection equipment. Some major companies operating in this business are Canon Inc., Keysight Technologies Inc., and Fortive Corp.
Advertisement
BMI and
Correlation & Price change
A.I.dvisor indicates that over the last year, BMI has been loosely correlated with BKSY. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if BMI jumps, then BKSY could also see price increases.
| Ticker / NAME | Correlation To BMI | 1D Price Change % | ||
|---|---|---|---|---|
| BMI | 100% | +13.48% | ||
| BKSY - BMI | 33% Loosely correlated | -3.80% | ||
| ARBE - BMI | 28% Poorly correlated | -6.04% | ||
| NOVT - BMI | 27% Poorly correlated | -2.34% | ||
| FTV - BMI | 26% Poorly correlated | +2.40% | ||
| TRMB - BMI | 23% Poorly correlated | +2.27% | ||
More | ||||
FCUV and
Correlation & Price change
A.I.dvisor tells us that FCUV and CGNX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FCUV and CGNX's prices will move in lockstep.
| Ticker / NAME | Correlation To FCUV | 1D Price Change % | ||
|---|---|---|---|---|
| FCUV | 100% | -3.25% | ||
| CGNX - FCUV | 23% Poorly correlated | -5.94% | ||
| VPG - FCUV | 21% Poorly correlated | -17.86% | ||
| TRMB - FCUV | 21% Poorly correlated | +2.27% | ||
| WATT - FCUV | 21% Poorly correlated | -0.11% | ||
| BMI - FCUV | 21% Poorly correlated | +13.48% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MBBB | 20.35 | N/A | N/A |
| VanEck Moody's Analytics BBB Corporate Bond ETF (MBBB) | |||
| GMAR | 45.34 | -0.15 | -0.33% |
| FT Vest U.S. Equity Moderate Buffer ETF - March (GMAR) | |||
| DDTY | 20.74 | -0.13 | -0.65% |
| Innovator Equity Dual Directional 10 Buffer ETF - MAY (DDTY) | |||
| BBP | 103.96 | -0.98 | -0.94% |
| Virtus Biotech ETF (BBP) | |||
| IWL | 189.49 | -2.75 | -1.43% |
| iShares Russell Top 200 ETF (IWL) | |||